|Room 4331, 3th building, high-tech industrial park, yizhi road, qingshan district, wuhan, China||Body@bodybiological.com|
|Place of Origin:||Hubei, China|
|Model Number:||CAS: 54965-24-1|
|Minimum Order Quantity:||10g|
|Packaging Details:||Foil bag|
|Delivery Time:||Within 24 hours after the payment|
|Payment Terms:||T/T, Western Union, MoneyGram|
|Delivery Time:||Within 24 Hours After The Payment||Shipping Way:||FEDEX, TNT, UPS, DHL, Airmail, HK EMS...|
|Payment Terms:||Money Gram, Western Union, T/T||Policy:||Resending Policy|
|Appearance:||White Powder And Tablets||Whatsapp:||+8613264710010|
10mg Tablet Nolvadex Injectable Anabolic Steroids Tamoxifen Citrate
Synonyms: kessar; noltam; tamofen
Character: White crystalline powder
MP: 140-144 degrees
Tamoxifen Citrate is the only medicine being able to stop cancer tumor in breast tissues and kill cancer. Recent statistics has revealed that male beast cancer keeps the pace with female disease. Tamoxifen citrate is available on the pharmaceutical market with prescription from your doctor. The drug may be marketed under another brand name which is Nolvadex. It is also available under the brand name Soltamox. We recommend Nolvadex. Thus buy Nolvadex online as this is the same Tamoxifen Citrate. In this review we are discussing the risks of treatment with Tamoxifen, the probable results of treatment and prevention as well as about alternative ways of getting recovered from breast cancer.
How Tamoxifen Citrate treats cancer?
Tamoxifen CitrateMost cancer tumors which develop in female or male body are estrogen dependent malformations. This medicine affects the receptors of estrogen (certain structures in breast tissues). This formations look like lumps which in most cases cause a change of size and shape of a damaged breast. But on the early stages the disease does not show any evidences. A patient does not feel either pain or discomfort. The palpating examination does not show any evidences on new formations in the breast tissues. A woman may not notice none of the typical signs of breast cancer as liquid from the nipples, redness and patching of skin, swelling of the lymph nodes.
These symptoms get present on the late stages of the disease when conservative treatment almost impossible.
Tamoxifen Citrate is the best way to start. Breast cancer tumors begin to grow due to effect of estrogens on certain abnormal cells which have lost their normal ability to develop, part and stop parting. Under the action of estrogen these cells start to grow chaotically. They do not attach to other cells to which they belong. Thus these cells lose their connection with the tissues a part of which they were. In this very moment these cells start to grow in a new cancer tissue and damage the healthy tissues nearby.
Tamoxifen works by blocking estrogen receptors thus preventing the «nutrition» of cancer cells. Tamoxifen citrate can be equally effectively used as in men so in women with prescriptions from a doctor being a must have. The drug has been tested in various medical trials and has shown efficacy in treatment of various types of malformations in different parts of the body. However only your doctor may decide which medicine will be an optimum solution for treatment of any individual cancer case.
Usually it is used as an auxiliary medication in women and men who already have passed radiation, chemotherapy or surgery being radical types of treatment for any type of treatment. In some cases Tamoxifen citrate is prescribed to women with high risks of developing a more dangerous types of cancer. Some types of breast tumors get located in a certain area of breast tissues (for example, milk duct) and do not spread to other tissues of breast or other body parts. However nobody can predict which way the disease will develop later on. In most cases Tamoxifen Citrate prevents the cancer tumor from growing and spreading.
Apart from cancer treatment the drug can be used to prevent breast cancer as well as other estrogen dependent types of cancer in any part of the body. Tamoxifen ca be prescribed to women belonging to high or the highest risk groups of developing any type of malformations in breast tissues.
Sep 9, 2016
Sep 9, 2016
|Appearance||White crystalline powder||
|Loss on drying||Not more than 0.5%||
|Residue on ignition||Not more than 0.2%||
|Iron||Not more than 0.005%||
|Heavy metals||Not more than 0.001%||
|Related substances Total||Not more than 1.0%||
|Individual||Not more than 0.5%||
|E-isomer||Not more than 0.3%||
|Organic volatile impurities||Conforms||
Between 99.0% and 101.0% 99.51%
Conform with USP 30
|Analyst: Yang fang||
Checker: Cheng Dan
Supervisor: Li Lili
Indications and Usage
For the treatment of node-positive breast cancer in postmenopausal women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation; for the treatment of axillary node-negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation; in women with ductal carcinoma in situ (DCIS) following breast surgery and radiation to reduce the risk of invasive breast cancer; treatment of metastatic breast cancer in women and men; to reduce the incidence of breast cancer in women at high risk of breast cancer.
Ovulation stimulation in specially selected anovulatory women desiring pregnancy; management and treatment of some types of mastalgia (eg, cyclical); malignant carcinoid tumor and carcinoid syndrome; migraine associated with menstruation; oligozoospermia; McCune-Albright syndrome in female pediatric patients (in combination with other agents); metastatic melanoma; desmoid tumors; gynecomastia.
Hypersensitivity to drug; women who require concomitant coumarin-type anticoagulant therapy or women with a history of deep vein thrombosis (DVT) or pulmonary embolus (PE) (reduction of breast cancer incidence in high-risk women/DCIS only).